Post by
Stockwonder on Jun 28, 2021 9:36am
Sernovas Cell Pouch technology works well.
This is huge. The patient is very happy with this. a billion dollar market now opens to Sernova.
Comment by
MustangSalley on Jun 28, 2021 9:50am
Yes the first patient is insulin independent .... but from the portal vein top up or from the pouch itself? The other patients are not insulin independent so far . Immunosuppresion needs to be solved for a cure for TD1 . Sva apparently has a solution , but for some reason nothing has been done with immune coating. Let's hope it does not go the way of Serotoli cells.
Comment by
BioTeck on Jun 28, 2021 10:02am
Sertoli, Age-X, Conformal Coating. 3 strikes and you're out? Sernova should really just sell it's pouch (patents) to Vertex at 500 million. However, that ship has probably already sailed.